PARAFLEX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Paraflex, and when can generic versions of Paraflex launch?
Paraflex is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in PARAFLEX is chlorzoxazone. There are sixteen drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Paraflex
A generic version of PARAFLEX was approved as chlorzoxazone by AUROBINDO PHARMA LTD on May 4th, 1988.
Summary for PARAFLEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 137 |
| Patent Applications: | 3,691 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | PARAFLEX at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for PARAFLEX
US Patents and Regulatory Information for PARAFLEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | PARAFLEX | chlorzoxazone | TABLET;ORAL | 011300-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
